Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1215854.RAmn5Z_0EpuQDUdL1PCeUM50iLALnMDJ2a9AAS5dy34iM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1215854.RAmn5Z_0EpuQDUdL1PCeUM50iLALnMDJ2a9AAS5dy34iM130_assertion type Assertion NP1215854.RAmn5Z_0EpuQDUdL1PCeUM50iLALnMDJ2a9AAS5dy34iM130_head.
- NP1215854.RAmn5Z_0EpuQDUdL1PCeUM50iLALnMDJ2a9AAS5dy34iM130_assertion description "[The renin-angiotensin-aldosterone system blockade is central to the current treatment of patients with chronic kidney disease (CKD) for the renoprotective effects aimed to prevent or slow progression to end-stage renal disease (ESRD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1215854.RAmn5Z_0EpuQDUdL1PCeUM50iLALnMDJ2a9AAS5dy34iM130_provenance.
- NP1215854.RAmn5Z_0EpuQDUdL1PCeUM50iLALnMDJ2a9AAS5dy34iM130_assertion evidence source_evidence_literature NP1215854.RAmn5Z_0EpuQDUdL1PCeUM50iLALnMDJ2a9AAS5dy34iM130_provenance.
- NP1215854.RAmn5Z_0EpuQDUdL1PCeUM50iLALnMDJ2a9AAS5dy34iM130_assertion SIO_000772 25176603 NP1215854.RAmn5Z_0EpuQDUdL1PCeUM50iLALnMDJ2a9AAS5dy34iM130_provenance.
- NP1215854.RAmn5Z_0EpuQDUdL1PCeUM50iLALnMDJ2a9AAS5dy34iM130_assertion wasDerivedFrom befree-2016 NP1215854.RAmn5Z_0EpuQDUdL1PCeUM50iLALnMDJ2a9AAS5dy34iM130_provenance.
- NP1215854.RAmn5Z_0EpuQDUdL1PCeUM50iLALnMDJ2a9AAS5dy34iM130_assertion wasGeneratedBy ECO_0000203 NP1215854.RAmn5Z_0EpuQDUdL1PCeUM50iLALnMDJ2a9AAS5dy34iM130_provenance.